Concepedia

Kerry A. Rogers

KA

57

Publications

4K

Citations

31

H-Index

2015

Active since

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

The Ohio State University Wexner Medical Center

Kerry A. Rogers is an author at The Ohio State University specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

2015–2024

57

Publications

57

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 927 citations · Full text

<i>BTK</i><sup>C481S</sup>-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Jennifer A. Woyach, Amy S. Ruppert, Daphne Guinn et al. · Journal of Clinical Oncology · 2017 · 461 citations · Full text

, , +14

Hypertension and incident cardiovascular events following ibrutinib initiation

Tyler Dickerson, Tracy Wiczer, Allyson Waller et al. · Blood · 2019 · 237 citations · Full text

The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation

Sean D. Reiff, Rose Mantel, Lisa L. Smith et al. · Cancer Discovery · 2018 · 161 citations · Full text

Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Tracy Wiczer, Lauren Levine, Jessica Brumbaugh et al. · Blood Advances · 2017 · 158 citations · Full text

, , +19

Rows per page

1–5 of 57